Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosus, Subacute Cutaneous”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Not applicableStudy completedNCT01923415
What this trial is testing

A Non-drug Study Profiling Cutaneous Lupus

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, SystemicLupus Erythematosus, Discoid
Janssen Research & Development, LLC 29
Testing effectiveness (Phase 2)Ended earlyNCT01407679
What this trial is testing

Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Cutaneous
University Hospital Muenster 7
Large-scale testing (Phase 3)Looking for participantsNCT07355218
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Who this might be right for
Systematic Lupus ErythematosusCutaneous Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 202
Large-scale testing (Phase 3)Enrolling By InvitationNCT06044337
What this trial is testing

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 306
Testing effectiveness (Phase 2)Active Not RecruitingNCT04857034
What this trial is testing

Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Who this might be right for
Lupus Erythematosus, DiscoidLupus Erythematosus, Subacute Cutaneous
Bristol-Myers Squibb 74
Large-scale testing (Phase 3)Active Not RecruitingNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 450
Not applicableWithdrawnNCT00222183
What this trial is testing

Cutaneous Lupus Erythematosus and Elidel

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, Discoid
University of Leipzig
Large-scale testing (Phase 3)Looking for participantsNCT07332481
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc. 202
Testing effectiveness (Phase 2)Study completedNCT04781816
What this trial is testing

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus
Sanofi 78
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Testing effectiveness (Phase 2)Active Not RecruitingNCT05540327
What this trial is testing

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Who this might be right for
Systemic Lupus Erythematosus
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 379
Testing effectiveness (Phase 2)Looking for participantsNCT07694336
What this trial is testing

Quinacrine in Participants With Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Victoria Werth 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06980805
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Immunovant Sciences GmbH 56
Post-approval studies (Phase 4)Looking for participantsNCT06875960
What this trial is testing

Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Who this might be right for
Systemic Lupus Erythematosus (SLE)Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Bristol-Myers Squibb 35
Not applicableStudy completedNCT02125695
What this trial is testing

Pilot Tape Harvesting Study

Who this might be right for
Atopic DermatitisHealthyDiscoid Lupus Erythematosus+1 more
Biogen 37
Testing effectiveness (Phase 2)Study completedNCT01294774
What this trial is testing

Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus Erythematosus
Novartis Pharmaceuticals 10
Early research (Phase 1)Ended earlyNCT01389895
What this trial is testing

Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous LupusLupus
Amgen 1
Large-scale testing (Phase 3)Active Not RecruitingNCT06015737
What this trial is testing

A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus
AstraZeneca 339
Early research (Phase 1)Study completedNCT06013995
What this trial is testing

Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

Who this might be right for
Lupus
Bristol-Myers Squibb 45
Not applicableStudy completedNCT02034344
What this trial is testing

Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, SystemicLupus Erythematosus, Discoid+1 more
Janssen Research & Development, LLC 77
Next Page